Abid Hussain
@amh10.bsky.social
Medical Microbiologist & Clinical Services Director @UKHSA BPHL. All posts my own. #QI #ClinGov
My thoughts on AMS and where we are heading: www.linkedin.com/pulse/stewar...
Stewardship 2.0: Harnessing Data, Tech, and Teamwork to Save Antibiotics
When we think about the rise of antibiotic-resistant superbugs, our minds typically go to one place: the unwell patient. The prevailing wisdom is that antimicrobial resistance (AMR) is a direct conseq...
www.linkedin.com
October 4, 2025 at 7:25 PM
My thoughts on AMS and where we are heading: www.linkedin.com/pulse/stewar...
Resolving a NICU outbreak of meticillin-resistant Staphylococcus aureus to the single-nucleotide variant level using Oxford Nanopore simplex reads and HERRO error correction www.journalofhospitalinfection.com/article/S019... @alanmcn1.bsky.social @wvschaik.bsky.social @jessicamablair.bsky.social
Resolving a neonatal intensive care unit outbreak of meticillin-resistant Staphylococcus aureus to the single-nucleotide variant level using Oxford Nanopore simplex reads and HERRO error correction
Our laboratory began prospective genomic surveillance for healthcare-associated organisms
in 2022 using Oxford Nanopore Technologies (ONT) as a standalone platform. While effective
for early outbreak ...
www.journalofhospitalinfection.com
September 6, 2025 at 7:01 PM
Resolving a NICU outbreak of meticillin-resistant Staphylococcus aureus to the single-nucleotide variant level using Oxford Nanopore simplex reads and HERRO error correction www.journalofhospitalinfection.com/article/S019... @alanmcn1.bsky.social @wvschaik.bsky.social @jessicamablair.bsky.social
Advancements in urinary tract infections: understanding, prevention, diagnosis, and treatment doi.org/10.1177/2049...
Advancements in urinary tract infections: understanding, prevention, diagnosis, and treatment - Bhaskar K. Somani, 2025
doi.org
September 6, 2025 at 6:51 PM
Advancements in urinary tract infections: understanding, prevention, diagnosis, and treatment doi.org/10.1177/2049...
Empiric antibiotics for moderate-severe community-Acquired Pneumonia: We ought to serve patients better! - More studies needed www.clinicalmicrobiologyandinfection.org/article/S119...
Empiric antibiotics for moderate-severe community-Acquired Pneumonia: We ought to serve patients better!
Each day thousands of patients are hospitalized worldwide with Community-Acquired
Pneumonia (CAP), either radiologically confirmed or presumed based on clinical symptoms
only, and each day physicians ...
www.clinicalmicrobiologyandinfection.org
September 6, 2025 at 6:49 PM
Empiric antibiotics for moderate-severe community-Acquired Pneumonia: We ought to serve patients better! - More studies needed www.clinicalmicrobiologyandinfection.org/article/S119...
Reposted by Abid Hussain
Read this properly now and it really is a staggeringly beautiful study. And super important. Opens a new avenue of research I reckon. One of my papers of the year.
So excited our antibiotic potentiation story is out 🤩 Led by the extraordinary @manonlang.bsky.social with @fox-science.bsky.social & @amazeld.bsky.social +amazing collaborators @immunobladder.bsky.social @imaneelmeouche.bsky.social 🦠 We believe it can make a difference in #AMR infections!
Uridine as a potentiator of aminoglycosides through activation of carbohydrate transporters
Uridine boosts aminoglycoside treatment efficiency against antibiotic-susceptible as well as antibiotic-resistant E. coli strains.
www.science.org
September 6, 2025 at 6:43 PM
Read this properly now and it really is a staggeringly beautiful study. And super important. Opens a new avenue of research I reckon. One of my papers of the year.
Cardiac Manifestations of Mycoplasma pneumoniae Infections: A Cohort Study 2007–2024 url: academic.oup.com/cid/article/...
Cardiac Manifestations of Mycoplasma pneumoniae Infections: A Cohort Study 2007–2024
A 17-year cohort shows higher incidence of cardiac involvement than previously reported in patients admitted with Mycoplasma pneumoniae infections that may
academic.oup.com
September 6, 2025 at 6:44 PM
Cardiac Manifestations of Mycoplasma pneumoniae Infections: A Cohort Study 2007–2024 url: academic.oup.com/cid/article/...
Teicoplanin total trough concentration and adverse effects in patients with hypoalbuminemia - Journal of Infection and Chemotherapy www.jiac-j.com/article/S134...
Teicoplanin total trough concentration and adverse effects in patients with hypoalbuminemia
The association between Teicoplanin (TEIC) total trough concentration (Cmin) and adverse
effects (hepatotoxicity, nephrotoxicity, and thrombocytopenia) in patients with hypoalbuminemia
remains poorly ...
www.jiac-j.com
September 6, 2025 at 6:40 PM
Teicoplanin total trough concentration and adverse effects in patients with hypoalbuminemia - Journal of Infection and Chemotherapy www.jiac-j.com/article/S134...
The international and intercontinental spread and expansion of antimicrobial-resistant Salmonella Typhi: a genomic epidemiology study - The Lancet Microbe www.thelancet.com/journals/lan...
The international and intercontinental spread and expansion of antimicrobial-resistant Salmonella Typhi: a genomic epidemiology study
Independent acquisition of plasmids and homoplastic mutations conferring antimicrobial
resistance have occurred repeatedly in multiple lineages of S Typhi, predominantly
arising in south Asia before s...
www.thelancet.com
July 15, 2025 at 8:30 PM
The international and intercontinental spread and expansion of antimicrobial-resistant Salmonella Typhi: a genomic epidemiology study - The Lancet Microbe www.thelancet.com/journals/lan...
Reposted by Abid Hussain
To tackle antibiotic resistance (#AMR) in newborns, especially premature babies in #NICUs, researchers explored the best trial design for studying #IPC.
See what this simulation study, based on #NeoIPC data and presented at #ESCMIDGlobal, suggests 👇
View poster: neoipc.org/wp-content/u...
See what this simulation study, based on #NeoIPC data and presented at #ESCMIDGlobal, suggests 👇
View poster: neoipc.org/wp-content/u...
April 18, 2025 at 2:35 PM
To tackle antibiotic resistance (#AMR) in newborns, especially premature babies in #NICUs, researchers explored the best trial design for studying #IPC.
See what this simulation study, based on #NeoIPC data and presented at #ESCMIDGlobal, suggests 👇
View poster: neoipc.org/wp-content/u...
See what this simulation study, based on #NeoIPC data and presented at #ESCMIDGlobal, suggests 👇
View poster: neoipc.org/wp-content/u...
Candida diagnostics in endovascular infections. Is @brukercorporation.bsky.social #MALDI better for Candida pararugosa? #ESCMID2025
April 15, 2025 at 9:31 AM
Candida diagnostics in endovascular infections. Is @brukercorporation.bsky.social #MALDI better for Candida pararugosa? #ESCMID2025
Reposted by Abid Hussain
Get ready! The Clinical Grand Round is about to begin in Hall 1. Six renowned experts take on seven tough #infectiousdisease cases. Don’t miss the excitement and insights as they solve complex clinical challenges at #ESCMIDGlobal 2025!
April 15, 2025 at 6:23 AM
Get ready! The Clinical Grand Round is about to begin in Hall 1. Six renowned experts take on seven tough #infectiousdisease cases. Don’t miss the excitement and insights as they solve complex clinical challenges at #ESCMIDGlobal 2025!
Reposted by Abid Hussain
Don't miss this one from Dr. Noor Zaidan and team as they provide insight on optimal recurrent Cdiff infection at #ESCMIDGlobal 2025! 🦠
Key point: Sequential use of fidaxomicin and vancomycin did not significantly impact CDI recurrence rate within 8 weeks at UTMB Health. @rachelbpharmd.bsky.social
Key point: Sequential use of fidaxomicin and vancomycin did not significantly impact CDI recurrence rate within 8 weeks at UTMB Health. @rachelbpharmd.bsky.social
April 15, 2025 at 8:01 AM
Don't miss this one from Dr. Noor Zaidan and team as they provide insight on optimal recurrent Cdiff infection at #ESCMIDGlobal 2025! 🦠
Key point: Sequential use of fidaxomicin and vancomycin did not significantly impact CDI recurrence rate within 8 weeks at UTMB Health. @rachelbpharmd.bsky.social
Key point: Sequential use of fidaxomicin and vancomycin did not significantly impact CDI recurrence rate within 8 weeks at UTMB Health. @rachelbpharmd.bsky.social
Reposted by Abid Hussain
I’ve long admired the approach of #ECIL on febrile neutropenia in hemato-oncology/HSCT patients which informed our local guidelines. So grateful to hear Prof Averbuch re: updates to ECIL FN GL 🙏
De-escalate early beneficial
Know colonization hx and local epi
#ESCMIDGlobal
#antimicrobialstewardship
De-escalate early beneficial
Know colonization hx and local epi
#ESCMIDGlobal
#antimicrobialstewardship
April 15, 2025 at 7:32 AM
I’ve long admired the approach of #ECIL on febrile neutropenia in hemato-oncology/HSCT patients which informed our local guidelines. So grateful to hear Prof Averbuch re: updates to ECIL FN GL 🙏
De-escalate early beneficial
Know colonization hx and local epi
#ESCMIDGlobal
#antimicrobialstewardship
De-escalate early beneficial
Know colonization hx and local epi
#ESCMIDGlobal
#antimicrobialstewardship
Always talk of the PO PKPD #ESCMID2025
April 15, 2025 at 7:53 AM
Always talk of the PO PKPD #ESCMID2025
Why is this not happening #ESCMID2025
April 15, 2025 at 7:16 AM
Why is this not happening #ESCMID2025
